<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Frank Alfieri on Medium]]></title>
        <description><![CDATA[Stories by Frank Alfieri on Medium]]></description>
        <link>https://medium.com/@frankalfieri?source=rss-fc5565e5c840------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/0*2LPurExKI2a7aa87.</url>
            <title>Stories by Frank Alfieri on Medium</title>
            <link>https://medium.com/@frankalfieri?source=rss-fc5565e5c840------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Fri, 20 Nov 2026 06:37:22 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@frankalfieri/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Amazon : The Medicine Man]]></title>
            <link>https://medium.com/@frankalfieri/amazon-the-medicine-man-4cc7622c3908?source=rss-fc5565e5c840------2</link>
            <guid isPermaLink="false">https://medium.com/p/4cc7622c3908</guid>
            <category><![CDATA[amazon-pharma]]></category>
            <category><![CDATA[precision-medicine]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Frank Alfieri]]></dc:creator>
            <pubDate>Wed, 28 Mar 2018 22:36:55 GMT</pubDate>
            <atom:updated>2018-03-28T22:44:14.989Z</atom:updated>
            <content:encoded><![CDATA[<p>#NewHealthCompany</p><p>Disclaimer: Long read with links, videos and excerpts.</p><p>Let’s start with an excerpt from an interview with (in part) Nathaniel David, CEO of Unity Biotechnologies. Moderated by Frank Swain, journalist at New Scientist. Watch from 15:35 to 21:30…</p><p>Moderator: <em>“Unity Biotechnologies is producing a drug that has a market of 7 billion people…”</em></p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2F-rB63W4pN8Y%3Ffeature%3Doembed&amp;url=http%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3D-rB63W4pN8Y&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2F-rB63W4pN8Y%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/8a11a5b7bd3be9e854d43a047458c40f/href">https://medium.com/media/8a11a5b7bd3be9e854d43a047458c40f/href</a></iframe><p>There’s no doubt that Amazon is getting into the pharma business. Man has been using medication since the beginning of time. Derived mostly from botanicals at the outset, drug development is now reaching new heights with the ubiquity of data and its analysis.</p><p>We can’t begin to speculate about Amazon digging its heals into the healthcare market when the market “analysts” tell us so. While it recently started a buzz on the internet, the Amazon foray into pharma started a very long time ago.</p><p>All we really need to do is follow the money trail to begin. Amazon sells us stuff. So, the two common denominators as far as transactions are concerned are “WE” (the consumers), and “Amazon” (the seller). Without either, the transaction would not be possible. So, the longer we are alive and active, the more we can be of benefit to Amazon, and Amazon to us, so to speak.</p><p>The secondary elements that have the same clout for Amazon to be profitable is access. WE need the internet to enter into a contractual agreement with Amazon to ship stuff to our stoops. In essence really, we need a stoop, and an internet connection. Pretty common ground for modern families.</p><p>It’s been years that Amazon has been making substantial financial investments in spheres related to pharma. My intuition has it that they are not merely going to let this one go as a low level “let’s get a piece of this market” investment round. They are going long term and global, looking at health, lifespan and terminal illness cure development.</p><p>After all, if the customer is not alive and well, then they can’t be a customer. One of the most interesting findings of WHY Amazon will enter pharma can be found from some of their more recent investments…</p><p>Investment in Unity Biotechnology. In October 2016 Bezos Expeditions invested $116M in Unity Biotech. That’s a 75% percent stake in Unity Biotechnologies. In a nutshell this is what Unity Biotechnology does:</p><p><em>“Imagine a future in which you age, but without the diseases your parents got. A future in which it doesn’t hurt to grow old.”</em></p><blockquote>At UNITY, we design therapeutics that prevent, halt, or reverse diseases of aging. Our medicines are designed to lengthen health span, the amount of time you live in good health.</blockquote><p>And here is the market that Amazon Pharma is targeting with the Unity Biotech investment:</p><blockquote>When the world’s over-60 population doubles to two billion in 2050, one in four humans will be old. Historically, old age has meant arthritis, heart disease, kidney failure, loss of eyesight, and loss of hearing. We’re targeting fundamental mechanisms at the root of age-related diseases. Our medicines could make many debilitating consequences of aging as uncommon as polio.</blockquote><p>What’s interesting in this last quote is the fact that Amazon’s current primary customers are going to be over 60 years of age by the year 2050. That gives them a current median age of 37. That fits the Amazon current customer profile perfectly.</p><p>If you use some imagination to see into the future, then we have two fundamental things going on in healthcare:</p><p>One: Amazon Pharma will be producing and distributing anti-aging drugs.</p><p>Two: By removing senescent cells from the body regularly, there won’t be any need for other current common drugs that cure the ailments of humankind.</p><p>Will pharma be disrupted? : YES</p><p>Will Amazon be a part of it? : YES</p><p>This is when the paradigm of human healthcare changes. Governments will reform healthcare policies in line with keeping their populations healthy. Healthcare insurers on the other hand will need to reformulate their antiquated actuarial models that determine the cost and risk factors associated with insuring people. Unity and Amazon’s new drugs suppressing the need for other drugs (cost to insurers) will revolutionize the healthcare industry. If Amazon could supply a drug that suppresses the need for other drugs, at a lower cost per person, per year of life, then Amazon wins.</p><p>To learn more about Unity Biotechnologies, visit their website:</p><p><a href="https://unitybiotechnology.com/">Unity Biotechnology.com</a></p><p>One year after the Bezos Expeditions investment of $116M, the CEO of Unity Biotech explains what they hope to achieve:</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2F5YQDd8whJAA%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3D5YQDd8whJAA&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2F5YQDd8whJAA%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/fc13c7236cd9df4b370c1216a28ada42/href">https://medium.com/media/fc13c7236cd9df4b370c1216a28ada42/href</a></iframe><p>Before I continue with other key investments from the Bezos empire, we need to touch upon the scientific study of molecular genome sequencing. The research for this article took me to some pretty interesting places (on the web of course). Namely, one of the most popular is the ability to get to the very fabric of human composition, our DNA.</p><p>For most of you, when you think DNA processing, you can relate it to TV and online ads from the likes of <a href="https://mediacenter.23andme.com/">23andMe</a>, and <a href="https://www.ancestry.com/?geo_a=r&amp;geo_s=us&amp;geo_t=us&amp;geo_v=2.0.0&amp;o_xid=62916&amp;o_lid=62916&amp;o_sch=Partners">Ancestry.com</a>. Both companies can send you home kits that include a cotton swab to stick in your mouth and provide them with a DNA sample from your saliva for analysis sequencing, computation and storage. For a nominal fee they can tell you some interesting historical facts about you, your family and your susceptibility to disease along the spectrum of healthcare.</p><p>What’s interesting about this new genome DNA sequencing is the ramification it will have on healthcare. Now, we could not begin to speak healthcare without talking insurance. The two go hand in hand.</p><p>Whereas insurance companies from the past would have screening tests and questions to see how “insurable” you are (or what your actuarial risk will be), the game seems to be changing. Previously, lifestyle habits, diet, and activity levels were all part of insurance questionnaires. For the future however, life insurance companies may just well test your DNA for less than $100 bucks. Add some scale to that, and the fact that it will greatly enhance their actuarial risk profile assessment, and we’re talking big leagues.</p><p>In a nutshell, the foray into healthcare is a tightly knit fabric between technology and drugs. Amazon is already capitalizing on technology, but now they need the drugs.</p><p>To best understand how genome and DNA sequencing are entering a new era in healthcare and insurance, I found one particular article from MIT Technology Review that spells it out quite well:</p><p>Click on the image on the left to be redirected to the online article. The summary of DNA, genome, cancer and healthcare are summed up quite well.</p><p>The ramifications for healthcare and insurance can be described in more detail when looking at some of the notes on the 23andMe website. The mainstay of the website, which informs the user of DNA sequencing in layman’s terms also has a note amendment that is provided after clicking on “Important Test Information”….</p><p>Now, that’s interesting when we start talking insurance. If an insurance company would be aware of a genetic predisposition for let’s say a particular cancer in your family, would they still insure you? Is it even legal to reference a DNA sequencing test when providing insurance?</p><p>Let’s take a step out for a minute, and take a look at exactly how the pharma business works. There are a multitude of players in the scheme of things from the drug producer who injects all the R&amp;D money (usually backed by local governments), to the pharmacy, health insurers and PBM (pharmacy benefit managers). Business Insider put together an infographic to summarize how it happens:</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*oJIVJvk9FuDQ2o5rMotRFw.png" /></figure><p>If you would like to read the complete article for a clearer understanding, follow through with the link…</p><p><a href="http://www.businessinsider.com/express-scripts-esrx-anthem-not-renewing-pbm-2017-4">A huge pharma middleman just lost its biggest customer — and it shows how drug pricing really works. — Business Insider</a></p><p>For a more concise understanding of how a PBM (pharmacy benefit manager) operates, here is an excerpt:</p><blockquote>“Pharmacy Benefit Managers are the gate-keeping middlemen of the healthcare system. PBMs administer health plans for insurance companies and employers. They manage benefits and treatment costs for these organizations. The more organizations a PBM services, the greater number of patients (or lives, in insurance lingo) under its umbrella. With more lives comes more leverage when a PBM negotiates with pharmaceutical manufacturers for drug prices.</blockquote><blockquote><em>The three largest PBMs are Express Scripts, CVS and OptumRx, covering more than 80% of insured Americans. A PBM that manages tens of millions of lives has greater purchasing and negotiating power than a standalone company with 3,000 employees, or a pension plan with 20,000 lives, or even an independent insurance plan with just a few million lives. Among a slew of other services, PBMs primarily work with their clients to construct and administer a pharmacy benefit program, which is often referred to as a drug formulary. Formularies are just the lists of drugs that are approved or that have preferred pricing for the insurance company through a PBM’s negotiations with the drug’s maker. In exchange for placing its drug on formulary, a PBM receives a preferred price and a cash rebate from the drug’s manufacturer for every prescription it processes. Your insurance plan’s formulary is a major reason why your doctor prescribes you one drug company’s medicine over a competitor’s. Being the preferred drug is the goal. PBMs share a portion of the rebate it receives with their clients (the health plans) and patients receive the benefit of a drug at a preferred price. PBMs also collect fees for transactions and services it processes for its clients.” — </em><a href="https://www-forbes-com.cdn.ampproject.org/c/s/www.forbes.com/sites/stephenbrozak/2017/10/20/amazons-invasion-looms-over-healthcare/amp/?lipi=urn%3Ali%3Apage%3Ad_flagship3_search_srp_content%3BL8lj7XkvSry8QPm3eyoSYQ%3D%3D"><em>Forbes</em></a></blockquote><p>Along with that news and insight, we could also take a look at other elements in the news that Amazon might be scaring the pants off an old, established, highly regulated industry. Two of the most prominent news stories to surface recently are CVS acquiring Aetna, and Pfizer giving up the patent rights (3 years before expiration) to it’s ever world famous ($2B worldwide sales in 2012) impotency drug, Viagra.</p><p>Here are two of the best summary articles I could find on why and how:</p><blockquote>“Pfizer’s patent protecting Viagra from generic competition expires in April 2020, but Teva Pharmaceuticals USA Inc. will be allowed to launch its generic version in the United States on Dec. 11, 2017. Teva Pharmaceuticals USA is a division of Israeli-based Teva Industries Ltd.” — <a href="https://www.cbsnews.com/news/viagra-to-go-generic-in-2017-according-to-pfizer-agreement/">CBS News 2013</a></blockquote><p>Why would Pfizer give up such a lucrative drug before patent expiration? They’re most likely gearing up for the uprising of Amazon Pharma. I’m convinced.</p><p>Here is the news on CVS (pharmacy) buying it’s ($69M) closest insurance related market player…</p><p>Here is an excerpt:</p><blockquote>“The second reason CVS might see an advantage in buying Aetna is a single word that has appeared in a striking number of stories this year about any retailer that wants to keep making money: Amazon. Amazon is thought to be plotting a foray into pharmaceuticals — it reportedly has secured licenses that would allow it to sell, in 12 states, drugs, among other things. It could be the case that the company secured these licenses only to be able to sell medical devices, but analysts <a href="https://www.nytimes.com/2017/10/27/technology/amazon-pharmacy-drugs.html?dlbk">expect it has bigger ambitions</a> — perhaps it will start up an online pharmacy that could ship medications. These reports have health-care companies like CVS bracing for the presence of a new, ruthless competitor that has record of completely changing entire industries. The proposed CVS-Aetna merger was not exactly unexpected — the two companies, after first partnering seven years ago, have been growing ever closer — but anticipation of Amazon’s next moves could have hastened things.” — <a href="https://www.theatlantic.com/business/archive/2017/12/cvs-aetna-merger-deal-why/547442/">The Atlantic</a></blockquote><p>Here is another excerpt that explains the relationship between health insurance and pharma:</p><blockquote>“Insurers have been seeking closer relationships with consumers as they try to manage health-care costs, making sure that people seek care in the appropriate low-cost venues, and manage health conditions and adhere to taking medications rather than having expensive health emergencies.” — <a href="https://www.washingtonpost.com/news/wonk/wp/2017/10/26/why-cvs-health-would-want-to-buy-aetna/?utm_term=.82223a9080e9">The Washington Post</a></blockquote><p>These major moves in the industry that derives benefit from people consuming prescription drugs are all indications of an industry ripe for technological disruption.</p><p>That’s all short term heresay. Let’s get back to some key investments of the Bezos empire over the last couple of years. In addition to the $116M investment in anti-aging drug speculator Unity Biotechnologies, Amazon has also invested substantial resources into several other key market players…</p><p>The Bezos empire invested in Juno Therapeutics ($190M) and GRAIL ($100M).</p><p>GRAIL is a spinoff investment from DNA sequencing supercomputer fabricator Illumina. I’ll let you read those for yourself from WIRED and FastCo…</p><p><a href="https://www.wired.com/2017/04/geneticists-fear-illuminas-sequencers-may-distort-results/">The Go-To Gene Sequencing Machine With Very Strange Results — WIRED April 2017</a></p><p><a href="https://www.fastcompany.com/3061591/illumina-owns-the-dna-sequencing-market-now-its-building-an-app-store-too">Illumina, Secret Giant Of DNA Sequencing, Is Bringing Its Tech To The Masses</a> — <a href="https://www.fastcompany.com/3061591/illumina-owns-the-dna-sequencing-market-now-its-building-an-app-store-too">FastCo September 2016</a></p><p>Before ending this foray of research that took me into the inner workings of PBMs, DNA sequencing supercomputer manufacturers, and drug patents…let’s take a final look at Juno Therapeutics and GRAIL…</p><p><strong>Juno Therapeutics:</strong></p><blockquote>“Juno is developing autologous cellular biologics as an answer to overcoming tumor evasion and potentially eradicating cancer cells. We believe the type of engineered T cell we put in the body matters, and we have developed the capability to manipulate and control the type of cells a patient receives, allowing us to develop potential “best-in-class” products that could deliver optimal therapeutic impact.”</blockquote><p>To learn more about Juno Therapeutics and CAR and TCR technologies visit their website:</p><p><a href="https://www.junotherapeutics.com/">Juno Therapeutics</a></p><p>That leaves us with GRAIL, a spinoff of Illumina which produces the fancy hardware that sequences DNA…</p><p><strong>GRAIL:</strong></p><blockquote>“Human biology is complex, and research continues to reveal that the underlying mechanisms of cancer are even more diverse and elusive than previously understood — making early detection of cancer a challenge. Extensive research suggests that cancer may be directly detectable with DNA shed by tumors into the bloodstream. However, developing an effective early detection test that distinguishes between people with and without cancer is a “needle in a haystack” problem and requires harnessing data from hundreds of thousands of people. Together, this creates an unprecedented data challenge.”</blockquote><p>For more on GRAIL, visit their website:</p><p><a href="https://grail.com/">GRAIL</a></p><p>Finally, I will leave with this, to cap off this fascinating field of medicine, biotech and human genomes. It’s a quick five minute video from TED Ed, and explains in short, what a human genome is, and why it’s important for the future of healthcare:</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FMvuYATh7Y74%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DMvuYATh7Y74&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FMvuYATh7Y74%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/8840ac094b97141c336fee6bb7ae8dd3/href">https://medium.com/media/8840ac094b97141c336fee6bb7ae8dd3/href</a></iframe><p>Source: <a href="https://futurism.com/google-released-ai-analyzes-genome/">Google Released an AI That Analyzes Your Genome — Futurism</a></p><p>So, if Nathaniel David (CEO Unity Biotechnologies) is on target with his foray into re-inventing fire…by changing the “healthy” sweet spot lifespan of humans, then Amazon wins again when they enter pharma.</p><p>Amazon will be able to keep you in the sweet spot of your consumerism life for the longest time possible. All the other drugs won’t even be necessary. For one low price, and perhaps a monthly membership fee to Prime Plus, Amazon will sell you medication, insurance healthcare, and everything in between, from the moment of conception, until your last breath. All by Amazon.</p><p>Thanks for reading. I know it was long and complex. However, anything touching Amazon these days seems to be long and complex.</p><p>Comments and speculation welcomed.</p><p>Other key sources and further reading:</p><p><a href="https://en.wikipedia.org/wiki/Beijing_Genomics_Institute">Beijing Genomics Institute - Wikipedia</a></p><p><a href="https://www.bloomberg.com/news/articles/2017-01-17/where-the-u-s-actually-gets-its-drug-supply-quicktake-q-a">https://www.bloomberg.com/news/articles/2017-01-17/where-the-u-s-actually-gets-its-drug-supply-quicktake-q-a</a></p><ul><li><a href="https://en.wikipedia.org/wiki/Human_Genome_Project">Human Genome Project - Wikipedia</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470633/">Most of our prescription drugs are manufactured overseas - but are they safe?</a></li><li><a href="https://www.fiercepharma.com/marketing/text-to-save-drugs-pfizer-s-latest-vaigra-ad-includes-text-promotion-for-discounts">Pfizer&#39;s latest Viagra TV ad pitches mobile texting for discounts</a></li><li><a href="https://www.technologyreview.com/s/608207/china-genomics-giant-drops-plans-for-gene-edited-pets/">Tiny pigs made with science? Sorry, but they&#39;re not for sale</a></li><li><a href="https://www.technologyreview.com/s/511051/inside-chinas-genome-factory/">Inside China&#39;s Genome Factory</a></li><li><a href="https://www.technologyreview.com/s/609232/the-surgeon-who-wants-to-connect-you-to-the-internet-with-a-brain-implant/">This surgeon wants to connect you to the Internet with a brain implant</a></li><li><a href="https://www.cnbc.com/2017/05/16/amazon-selling-drugs-pharamaceuticals.html">Amazon is hiring people to break into the multibillion-dollar pharmacy market</a></li><li><a href="https://www.nytimes.com/2017/10/27/technology/amazon-pharmacy-drugs.html">Hearing Amazon&#39;s Footsteps, the Health Care Industry Shudders</a></li><li><a href="http://www.proactiveinvestors.co.uk/companies/news/188129/amazon-said-to-be-exploring-the-possibility-of-entering-pharmaceuticals-188129.html">Amazon said to be exploring the possibility of entering pharmaceuticals</a></li><li><a href="https://www.fiercepharma.com/special-report/top-10-u-s-patent-losses-2017">Top 10 U.S. patent losses of 2017</a></li><li><a href="http://www.marketwatch.com/story/is-amazon-getting-into-the-pharmacy-business-this-is-what-you-need-to-know-2017-10-09">Is Amazon getting into the pharmacy business? This is what you need to know</a></li><li><a href="https://www.bloomberg.com/news/articles/2017-11-07/six-ways-amazon-could-upend-the-pharmacy-business">This Is How Amazon Could Invade the Pharmacy Business</a></li><li><a href="https://www.cnbc.com/2017/11/02/amazon-pharmaceutical-move-acquisition-targets.html">Amazon should buy these companies if it wants to get into selling drugs</a></li><li><a href="http://www.sanger.ac.uk/">Home Page | Wellcome Sanger Institute</a></li><li><a href="http://www.bbc.com/news/science-environment-25576718">China cloning on &#39;industrial scale&#39;</a></li><li><a href="https://www.ncbi.nlm.nih.gov/books/NBK26837/">Isolating, Cloning, and Sequencing DNA - Molecular Biology of the Cell - NCBI Bookshelf</a></li></ul><iframe src="https://drive.google.com/viewerng/viewer?url=https%3A//www.trade.gov/topmarkets/pdf/Pharmaceuticals_Executive_Summary.pdf&amp;embedded=true" width="600" height="780" frameborder="0" scrolling="no"><a href="https://medium.com/media/ff2608394407ad6af245b896fec0b4ec/href">https://medium.com/media/ff2608394407ad6af245b896fec0b4ec/href</a></iframe><ul><li><a href="https://en.wikipedia.org/wiki/Pharmaceutical_industry">Pharmaceutical industry</a></li><li><a href="http://pharmaceuticalcommerce.com/business-and-finance/global-pharma-market-will-reach-1-12-trillion-2022/">Global pharma market will reach $1.12 trillion in 2022 - Pharmaceutical Commerce</a></li><li><a href="http://www.worldatlas.com/articles/countries-with-the-biggest-global-pharmaceutical-markets-in-the-world.html">Biggest Pharmaceutical Markets In The World By Country</a></li><li><a href="https://www.statista.com/statistics/266038/global-pharmaceutical-market-growth-since-2004/">Global pharmaceutical market: growth 2017 | Statistic</a></li><li><a href="https://www.statista.com/topics/1719/pharmaceutical-industry/">Topic: Pharmaceutical Industry in the U.S.</a></li><li><a href="https://www.drugwatch.com/2015/08/10/worldwide-prescription-drug-abuse/">Hooked on Pharmaceuticals: Prescription Drug Abuse in the World</a></li><li><a href="https://www.reuters.com/article/us-health-pharmaceuticals-spending/global-prescription-drug-spend-seen-at-1-5-trillion-in-2021-report-idUSKBN13V0CB">Global prescription drug spend seen at $1.5 trillion in 2021: report</a></li><li><a href="https://en.wikipedia.org/wiki/Pharmacy_benefit_management">Pharmacy benefit management</a></li><li><a href="https://www.thebalance.com/largest-pharmacy-benefit-managers-2663840">5 Largest Pharmacy Benefit Managers (PBMs) and How They Work</a></li><li><a href="https://www.fiercepharma.com/pharma/pfizer-s-legendary-viagra-finally-set-to-face-cheaper-competition">Pfizer&#39;s legendary Viagra finally set to face cheaper competition in U.S. | FiercePharma</a></li><li><a href="https://www.bloomberg.com/research/stocks/private/board.asp?privcapId=324565060">Unity Biotechnology, Inc.: Board of Directors - Bloomberg</a></li><li><a href="https://www.ncbi.nlm.nih.gov/books/NBK116452/">Emerging Technologies in Drug Development</a></li><li><a href="http://www.marketwatch.com/story/is-amazon-getting-into-the-pharmacy-business-this-is-what-you-need-to-know-2017-10-09">Is Amazon getting into the pharmacy business? This is what you need to know</a></li><li><a href="https://www.venrock.com/portfolio/">Portfolio - Venrock</a></li><li><a href="https://www.crunchbase.com/funding_round/grail-series-a--2cb3df1a">Series A - GRAIL - 2016-01-12 | Crunchbase</a></li></ul><p>End</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=4cc7622c3908" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Technological Singularity: Will Machines Become Smarter Than Man?]]></title>
            <link>https://medium.com/@frankalfieri/technological-singularity-will-machines-become-smarter-than-man-312a7bebdb53?source=rss-fc5565e5c840------2</link>
            <guid isPermaLink="false">https://medium.com/p/312a7bebdb53</guid>
            <category><![CDATA[artificial-intelligence]]></category>
            <category><![CDATA[machine-learning]]></category>
            <category><![CDATA[futurism]]></category>
            <category><![CDATA[singularity]]></category>
            <dc:creator><![CDATA[Frank Alfieri]]></dc:creator>
            <pubDate>Wed, 28 Mar 2018 14:19:57 GMT</pubDate>
            <atom:updated>2018-03-28T14:24:17.053Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-IM4rd8PBoUFrg1YliC3SA.jpeg" /></figure><blockquote>On the future of Artificial Intelligence: “Someday there will there will be a system that we built with our own hands that will open its eyes and look out and kind of have this buzz of being here that we have….and when that happens, that will be a major landmark moment in human history.” — Eric Horvitz. Technical Fellow, Microsoft. NATGEO.</blockquote><p>I was tuned in to a NATGEO documentary recently, and that was the quote that prompted some deep thought. “Year Million: Artificial Intelligence”.</p><p>To get a better idea of the content, you watch the full video here (47 minutes):</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2F-Xn6IDytVGw%3Ffeature%3Doembed&amp;url=http%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3D-Xn6IDytVGw&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2F-Xn6IDytVGw%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/2c129f66e88440895f169f58dfeecd05/href">https://medium.com/media/2c129f66e88440895f169f58dfeecd05/href</a></iframe><p>In 1996, over 20 years ago, Deep Blue, IBM’s AI prodigy beat the world’s chess grand master champion Garry Kasparov.</p><p>In 2011, the next iteration of IBM’s AI, Watson, goes on to defeat the best in the world at Jeopardy and won a million dollars. “What will AI do with a million dollars?”… is the prevailing question.</p><p>In 2016, AlphaGo defeated the world champion at the game of Go, widely considered to be the most complicated game on the planet.</p><p>Some pretty impressive stats if you ask me.</p><p>We can’t go on speaking of the human-machine synthesis without mentioning the name Ray Kurzweil. He’s a futurist and Google’s director of engineering. In his words from a recent article published on the subject…</p><blockquote>“That leads to computers having human intelligence, our putting them inside our brains, connecting them to the cloud, expanding who we are. Today, that’s not just a future scenario,” Kurzweil said. “It’s here, in part, and it’s going to accelerate.” — Ray Kurzweil, <a href="https://futurism.com/kurzweil-claims-that-the-singularity-will-happen-by-2045/">Futurism</a></blockquote><p>Another notable mention goes to Dr. Eric C. Leuthardt, a brain surgeon and neuroscientist specialist that has been researching, practicing and writing about the subject in length for most of his career. The recent article in MIT Technology Review is quite interesting and stimulating to say the least. It showcases the antecedent and current research developments on the subject of a plausible human-brain machine interface. You can find the complete article here:</p><p><a href="https://www.technologyreview.com/s/609232/the-surgeon-who-wants-to-connect-you-to-the-internet-with-a-brain-implant/"><strong>The Surgeon Who Wants To Connect You To The Internet With a Brain Implant</strong></a></p><blockquote>“The kinds of devices that people like Musk and Zuckerberg are talking about won’t just require better hardware to facilitate seamless mechanical connection and communication between silicon computers and the messy gray matter of the human brain. They’ll also have to have sufficient computational power to make sense out of the mass of data produced at any given moment as many of the brain’s nearly 100 billion neurons fire. One other thing: we still don’t know the code the brain uses. We will have to, in other words, learn how to read people’s minds.” — MIT Technology Review</blockquote><p>An interesting interpretation can be found here, in WIRED’s article from mid 2017. In it, there are some probing questions and answers from WIRED to Bryan Johnson. Johnson is the tech entrepreneur who sold his company Braintree to Paypal for $800M. He then went on to start Kernal, a startup that is exploring how to produce and implant chips into people with neurological disease. Here is the link to the complete article:</p><p><a href="https://www.wired.com/story/why-you-will-one-day-have-a-chip-in-your-brain/"><strong>Why You Will One Day Have A Chip In Your Brain</strong></a></p><p>To know more about what Kernal is doing, you may visit their website here:</p><p><a href="https://kernel.co/"><strong>Kernal.co</strong></a></p><p>I was about to stop this article here as my readings and research seemed to take me into a plethora of hypotheses and futurism that seems too odd to wrap my brain around….but I kept reading and pondering the fact that human evolution has come a long way, and just maybe, singularity is the be all, end all of the future of AI melded with human cognition.</p><p>If we look back a mere 25 years ago, I was in college and purchased my first home desktop computer with a student discount from the university computer lab. It was a 356 from IBM. I had removable access storage in the form of a floppy or hard disk, and the screen was stark black with a C:/ prompt. I remember it like it was yesterday.</p><p>Fast forward, and we are living on the cusp of self-driving cars, and computers that beat human world champions at very sophisticated strategy games. Technology has definitely advanced from the archaic 356 IBM that our family had in the study 25 years ago.</p><p>Nano technology and the future of quantum computing will advance the speeds at which tiny bots can think and react at a phenomenal pace. Imagine the day where you can text or conceive an email just by thinking about it.</p><p>That’s what some researchers have been doing to anticipate the language and thinking processes of songbirds. They have developed technology that can predict a Finch’s next song 30 milliseconds before it happens. Pretty cool.</p><blockquote>Facebook has said it hopes people will be able to type directly from their brains at 100 words per minute, privately sending texts whenever they want. A device able to read the commands your brain sends out to muscles while you are engaged in subvocal utterances (silent speech) is probably a lot more realistic than one that reads “thoughts.” — MIT Technology Review, October 2017</blockquote><p>Here is the link to the complete article:</p><p><a href="https://www.technologyreview.com/s/609032/scientists-can-read-a-birds-brain-and-predict-its-next-song/?utm_source=linkedin.com&amp;utm_medium=social&amp;utm_content=2017-03-03&amp;utm_campaign=Technology+Review"><strong>Scientists Can Read a Bird’s Brain and Predict Its Next Song</strong></a></p><p>Among the technologies that will spur the movement into singularity is quantum computing. In standard current modern day computing, technologies use 1’s and 0’s to produce a numerical language that can be read and interpreted by machines. In quantum computing technologies however a 1 or a 0 can mean two different things at the same time. A little confused? Read on in a recent article from WIRED in which quantum computing is defined and explained:</p><p><a href="https://www.wired.co.uk/article/quantum-computing-explained"><strong>What are quantum computers and how do they work?</strong></a></p><p>Quantum computing takes advantage of the strange ability of subatomic particles to exist in more than one state at any time. Due to the way the tiniest of particles behave, operations can be done much more quickly and use less energy than classical computers.</p><blockquote>In classical computing, a bit is a single piece of information that can exist in two states — 1 or 0. Quantum computing uses quantum bits, or ‘qubits’ instead. These are quantum systems with two states. However, unlike a usual bit, they can store much more information than just 1 or 0, because they can exist in any superposition of these values. — <a href="https://www.wired.co.uk/article/quantum-computing-explained">WIRED, February 2018</a></blockquote><p>For a more detailed description of quantum computing breakthroughs and where it’s headed read the following article:</p><p><a href="https://www-technologyreview-com.cdn.ampproject.org/c/s/www.technologyreview.com/s/610250/hello-quantum-world/amp/?utm_content=bufferdc3f0&amp;utm_medium=social&amp;utm_source=linkedin.com&amp;utm_campaign=buffer"><strong>Serious quantum computers are finally here. What are we going to do with them?</strong></a></p><blockquote>Inside IBM’s quantum lab, engineers are working on a version of the computer with 50 qubits. You can run a simulation of a simple quantum computer on a normal computer, but at around 50 qubits it becomes nearly impossible. That means IBM is theoretically approaching the point where a quantum computer can solve problems a classical computer cannot: in other words, quantum supremacy. — <a href="https://www-technologyreview-com.cdn.ampproject.org/c/s/www.technologyreview.com/s/610250/hello-quantum-world/amp/?utm_content=bufferdc3f0&amp;utm_medium=social&amp;utm_source=linkedin.com&amp;utm_campaign=buffer">MIT Technology Review, February 2018</a></blockquote><p>Some actual brain interfaces for human cognition and neurological interpretation are being developed by some of the greatest minds. The three videos below, from EmTech MIT Technology review, reveal how these interfaces are being developed and how advances in medicine will lead to the brain — machine interface.</p><p>Biomedicine editor Antonio Regalado asks speaker Mary Lou Jepsen (at 22:50 in the video) :</p><p><a href="https://www.technologyreview.com/video/609432/capturing-our-imagination-the-evolution-of-brain-machine-interfaces/">Capturing Our Imagination: The Evolution of Brain-Machine Interfaces</a></p><p>How do you study, categorize and interpret the firing patterns of 10 billion neurons in the brain? For human thought and speech to be studied and interpreted, we need to decipher the patterns of what happens in the neurons everytime we think of something or are about to think of something. That’s how we will evolve a technology that will read our minds and write what we are thinking…by decoding movement and thoughts into mathematically derived vectors and linking them tip to tail. Andrew Schwartz speaks of the developements in that sphere in the following video from EmTech MIT Technology Review:</p><p>If your going to watch any part of it, I suggest the 4 and a half minutes (excerpt from a 60 minutes episode) starting at 14:40, where biofeedback from a monkey’s brain allows it to move a prosthetic arm to reach for fruit and feed itself just by thinking about it…</p><p><a href="https://www.technologyreview.com/video/609400/next-generation-brain-interfaces/">Next-generation Brain Interfaces</a></p><p>On the subject of brain — computer interfaces and the applications that can be useful for it we can tune to Neurable’s CEO talk on the subject. Ramses Alcaide speaks of the future of these interfaces and how they will augment reality and allow for non-invasive thinking technolgies connected to our brain. To see the “thinking to typing” in action watch the video at 15:15. It’s about one letter per second right now, but will ramp up in the near future…</p><p><a href="https://www.technologyreview.com/video/609888/technology-spotlight-mind-controlled-vr/">Technology Spotlight: Mind-controlled VR</a></p><p>Wow is all I can say. All this research is quite impressive and fascinating. Thinking that just 25 short years ago I turned on my IBM 356 at home and was looking at a blank black screen with a green C:/ on it. We’ve come a long way. What will the next 25 years look like? That takes us to the evolution of these human — machine interfaces, quantum computing, and what the evolution of humanity will turn into because of these advances.</p><p>Will technological singularity be possible? When we begin sharing our thoughts with AI and machines, will they be able to learn enough to start thinking for themselves?</p><p><a href="https://en.wikipedia.org/wiki/Technological_singularity">Technological Singularity</a> from the Wiki page is described as:</p><blockquote>The <strong>technological singularity</strong> (also, simply, the <strong>singularity</strong>) <a href="https://en.wikipedia.org/wiki/Technological_singularity#cite_note-1">[1]</a> is the hypothesis that the invention of artificial<a href="https://en.wikipedia.org/wiki/Superintelligence">superintelligence</a> will abruptly trigger runaway technological growth, resulting in unfathomable changes to human civilization.<a href="https://en.wikipedia.org/wiki/Technological_singularity#cite_note-Singularity_hypotheses-2">[2]</a> According to this hypothesis, an upgradable <a href="https://en.wikipedia.org/wiki/Intelligent_agent">intelligent agent</a> (such as a computer running software-based <a href="https://en.wikipedia.org/wiki/Artificial_general_intelligence">artificial general intelligence</a>) would enter a “runaway reaction” of self-improvement cycles, with each new and more intelligent generation appearing more and more rapidly, causing an<a href="https://en.wikipedia.org/wiki/Intelligence_explosion">intelligence explosion</a> and resulting in a powerful superintelligence that would, qualitatively, far surpass all <a href="https://en.wikipedia.org/wiki/Human_intelligence">human intelligence</a>.</blockquote><p>The philosophical question behind this is…”What will be their motivation?” Throughout history and evolution man has been fueled by geographical domination and political power. Look at the the great dominations by the Roman Empire and/or the worldly dominations of the Mongol Empire or the British Empire. A list of world geographic domination empires throughout history can be found here:</p><p><a href="https://list25.com/25-largest-empires-in-history/"><strong>25 Largest Empires In History</strong></a></p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FTy9s31aKdlA%3Ffeature%3Doembed&amp;url=http%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DTy9s31aKdlA&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FTy9s31aKdlA%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/27807bcded7737057d15ce07686e3476/href">https://medium.com/media/27807bcded7737057d15ce07686e3476/href</a></iframe><p>When we think back along these lines, can we imagine a future of what machines will rate as the motivation for world dominance? Will it even be on their spectrum of priorities? If our antecedent brains have been wired for geographical and political dominance, will it be the same for machines? Probably not. They live in a machine world, not a physical one.</p><p>If we think about it systematically, man lives on earth and wants to acquire wealth and power by dominating populations and resources, which were in turn traded for wealth and imperialistic notions. Will machines want or even think to dominate this way? In my opinion, only if they are programmed by human brains to think this way.</p><p>We have been and are continuing to lay the physical groundwork for high speed transcontinental and satellite communications. High speed subsea cables are the essence of our high speed communcations world and sharing cognitive intelligence. However, for the time being, it’s being slowed down by the physical interfaces we are using to enter, decipher and eventually interpret these communications.</p><p>We have to physically “program” via a physical interface what we want machines to do. What happens when machines begin learning for themselves without a human programming interface?</p><p>For more on the connected subsea cables that connect our geographies for lightening fast communcations you can visit:</p><p><a href="https://www.submarinecablemap.com/">Submarine Cable Map</a></p><p>So, when machines start thinking for themselves, what will happen? What will be their motivations? Will it be geopolitical dominance? Will machines be able to recreate the dynasties that ruled the world since the beginning of time. When physical resources and geographical segregation are no longer important … what will become important?</p><p>Will machines and quantum qubits be able to detect minor occurences in neuro-cognitive cells when a cancer cell mutation in a human brain is about to be created and metastacised in the body? If that’s the way we teach them to think, then perhaps, it will be possible.</p><p>The crux of the issue then lies in education and moral instruction. When AI begins reading our thoughts and intentions, those very same thoughts and intentions will be of utmost importance. What we preach and teach to the current new generation of leaders will be important.</p><p>The larger question is when machines start talking to eachother, without the need for human intervention. Without human intervention, and without the need for physical things or resources, what will happen?</p><p>Wait a second, that can’t happen, because the very essence of machine stemmed from the creation of silicone chips and human cognition. So, it becomes a question of the chicken and the egg. Humans created machines intelligent enough to now speak to each other. Or did they?</p><p>Without the necessity of human intervention could a machine want to destroy the undersea communication cables of other machines that are vying for domination in a virtually disconnected world? … A world where virtually no physical things exist except the thoughts of human sentient cognition.</p><p>There are so many implications and questions to ponder on the future of technological singularity and machine intelligence. A fascinating field indeed.</p><p>What do you think will happen?</p><p>Comments and speculation are welcomed.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=312a7bebdb53" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>